GeraldBenjamin(Werthiem)WertheimMD
Pathology • Philadelphia, PAHematopathology, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology & Laboratory Medicine, Perelman School of Medicine
Dr. Wertheim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street
6 Founders
Philadelphia, PA 19104Phone+1 215-662-6503
Education & Training
University of Pennsylvania Health SystemFellowship, Hematopathology, 2009 - 2011- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2005
Certifications & Licensure
PA State Medical License 2005 - 2026
NJ State Medical License 2019 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Azacytidine Monotherapy in an Infant With Mosaic NRAS-Driven Juvenile Myelomonocytic Leukemia.Jeremy M Grenier, Sarah K Tasian, Elliot Stieglitz, Zied Abdullaev, Gerald B Wertheim
Pediatric Blood & Cancer. 2025-03-04 - Genetically Distinct Acute Megakaryoblastic Leukemia following Low Hypodiploid B-Lymphoblastic Leukemia linked byMutation.Jaryse C Harris, Jeffrey Schubert, Brian Lockhart, Rachel Olson, Michele E Paessler
Pediatric and Developmental Pathology. 2025-02-03 - Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologists.Dong Li, Sarah K Tasian, Gerald Wertheim, Susan R Rheingold, Kathrin M Bernt
Haematologica. 2025-01-30
Abstracts/Posters
- DYRK1A Is Regulated By Oncogenic KMT2A and Required for Survival of KMT2A-Rearranged Acute Lymphoblastic LeukemiaGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Lncrna Morrbid Regulates Myeloid Cell Survival of AML Driven By a Combination of FLT3ITD and Epigenetic MutationsGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Oncogene-Independent Adaptation of Pre-B Cell Receptor Signaling Confers Drug Resistance and Signaling Plasticity in Ph-like ALLGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
